It’s been more than two years since Eli Lilly introduced LillyDirect, a platform that combines telehealth and pharmacy services to provide access to Lilly’s portfolio of diabetes, migraine and obesity medicines. The goal is to provide a more transparent and affordable way to obtain certain medicines. The platform quickly attracted attention from both consumers and lawmakers.
To understand LillyDirect’s growth and future direction, senior writer Anastasia Guliadkovskaya spoke with Jen Mazur, senior vice president and general manager of LillyDirect and Consumer Services U.S.
Learn more about this episode’s topics:
Visited 6 times, 1 visit(s) today
